featured
Pirtobrutinib for Mantle Cell Lymphoma Previously Treated With a Covalent BTK Inhibitor
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Mantle Cell Lymphoma
J. Clin. Oncol 2023 May 16;[EPub Ahead of Print], ML Wang, W Jurczak, PL Zinzani, TA Eyre, CY Cheah, CS Ujjani, Y Koh, K Izutsu, JN Gerson, I Flinn, B Tessoulin, AJ Alencar, S Ma, D Lewis, E Lech-Maranda, J Rhodes, K Patel, K Maddocks, N Lamanna, Y Wang, CS Tam, T Munir, H Nagai, F Hernandez-Ilizaliturri, A Kumar, TS Fenske, JF Seymour, AD Zelenetz, B Nair, DE Tsai, M Balbas, RA Walgren, P Abada, C Wang, J Zhao, AR Mato, NN ShahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.